PharmaShots | Incisive News in 3 Shots

Subscribe Now

Gene therapy

Lysogene Receives the US FDA's Fast Track Designation for LYS-GM101 Gene Therapy to Treat GM1 Gangliosidosis

Lysogene Receives the US FDA's Fast Track Designation for LYS-GM101 Gene Therapy to Treat GM1 Gangliosidosis

July 9, 2021

Bayer to Advance its Investigational Cell and Gene Therapy for Parkinson's Disease

Bayer to Advance its Investigational Cell and Gene Therapy for Parkinson's Disease

June 9, 2021

Charles River to Acquire Vigene Biosciences for $292.5M

Charles River to Acquire Vigene Biosciences for $292.5M

May 17, 2021

UCB Acquires Handl Therapeutics to Augment its Gene Therapy Portfolio

UCB Acquires Handl Therapeutics to Augment its Gene Therapy Portfolio

November 13, 2020

$Kite's Tecartus (brexucabtagene autoleucel) Receives the US FDA's Approval as the First Cell-Based Gene Therapy for Relapsed or Refractory MCL$

Kite's Tecartus (brexucabtagene autoleucel) Receives the US FDA's Approval as the First Cell-Based Gene Therapy for Relapsed or Re...

July 27, 2020

Castle Creek Collaborates with Fibrocell to Develop and Commercialize FCX-007 Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB)

Castle Creek Collaborates with Fibrocell to Develop and Commercialize FCX-007 Gene Therapy for Recessive Dystrophic Epidermolysis...

April 16, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us